This trial the highest dose of retatrutide (12 mg) led to 16.9% weight loss (vs 3.0% with placebo) at 36 weeks
Weeks 4-8 may show slowing of hair loss and early signs of vellus hair growth in some users
What to Expect With Use of AOD-9604 Administration AOD-9604 is typically administered as a subcutaneous injection meaning a small injection into the fatty layer of skin, usually in the abdomen
Subcutaneous injection into the tissue adjacent to the tendon delivers high local concentration while allowing systemic distribution
Storing your semaglutide injection or tirzepatide at the wrong temperature doesn't just reduce effectivenessit may create unpredictable dosing outcomes that undermine your weight loss progress
[DOI] [PubMed] [Google Scholar] 246.Vlez P.A., Lara-Erazo V., Caballero-Lozada A.F., Botero A., Lozada G., Velsquez A.F., Villegas L.M., Zorrilla-Vaca A